This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cree Appoints Anne Whitaker To Board Of Directors

Cree, Inc. (Nasdaq: CREE) announces that Anne Whitaker, President, North American Pharmaceuticals, Sanofi S.A., has been appointed to the Company’s Board of Directors, effective December 2, 2013.

“We’re extremely pleased that Anne is joining our Board of Directors,” said Chuck Swoboda, Cree chairman and CEO. “Anne has proven herself to be a leader throughout her career and her extensive experience in strategic management and organizational development will be a tremendous asset to our Company as we continue to carry out our mission to accelerate the adoption of LED lighting.”

Whitaker joined Sanofi, a global and diversified healthcare leader, in September 2011. In her current role she oversees Sanofi’s operations within North America, and serves as a member of its Global Leadership Team and the U.S. Regional Strategic Management Committee.

A graduate of the University of North Alabama with more than 20 years of experience, Whitaker began her career as a metabolic disease specialist with Upjohn Company. From there she joined GlaxoSmithKline as a sales representative. After holding various leadership positions in GlaxoSmithKline’s commercial organization, in 2007 Whitaker became Vice President of Critical and Supportive Care before being appointed Senior Vice President of Leadership and Organization Development from 2008 to 2009. In 2009, Whitaker became Senior Vice President and Business Unit Head, Cardiovascular, Metabolic and Urology (CVMU) at GlaxoSmithKline, where she had full commercial responsibility for leading, developing and managing strategic performance of the CVMU business.

About Cree

Cree is leading the LED lighting revolution and making energy-wasting traditional lighting technologies obsolete through the use of energy-efficient, mercury-free LED lighting. Cree is a market-leading innovator of lighting-class LEDs, LED lighting, and semiconductor products for power and radio frequency (RF) applications.

Cree’s product families include LED fixtures and bulbs, blue and green LED chips, high-brightness LEDs, lighting-class power LEDs, power-switching devices and RF devices. Cree ® products are driving improvements in applications such as general illumination, backlighting, electronic signs and signals, power suppliers and solar inverters.

For additional product and company information, please refer to www.cree.com.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs